A trial looking at chemotherapy after surgery for cancer of the womb (EORTC 55102)

Please note - this trial is no longer recruiting patients. We hope to add results when they are available.

Cancer type:

Womb (uterine or endometrial) cancer




Phase 3

This trial is looking at having chemotherapy after surgery to remove womb (endometrial) cancer.

More about this trial

Doctors treat womb (endometrial) cancer with surgery. If the cancer hasn’t spread, you will see your specialist in the clinic at the hospital for 5 years. But unfortunately sometimes the cancer can come back.

We know from research that having chemotherapy after surgery to remove cancer can stop, or delay it, from coming back. The researchers want to find out if giving chemotherapy after surgery can help women whose womb cancer hasn’t spread.

To do this half the women in this trial will have carboplatin and paclitaxel chemotherapy after surgery. And the other half won’t.

The aims of this trial are to compare these 2 groups and find out

  • How long women live overall
  • How long they are alive and free of cancer
  • What the side effects are
  • What their quality of life Open a glossary item is

Who can enter

You may be able to join this trial if you are in one of the following situations. You have womb cancer that is

  • Stage 1 or stage 2 endometrioid type (if it is stage 1, it must be grade Open a glossary item 3)
  • Stage 1 or stage 2 clear cell, serous, squamous cell or undifferentiated type

You must also

  • Have had your womb and ovaries removed
  • Have had at least 12 lymph nodes Open a glossary item removed and there must be no cancer cells in your lymph nodes (your doctor can tell you this)
  • Have had surgery within the last 10 weeks
  • Have satisfactory blood tests
  • Be well enough to be up and about for at least half the day (performance status 0, 1 or 2)
  • Be at least 18 years old

You cannot join this trial if any of these apply. You

Trial design

This is an international phase 3 trial. The researchers need 678 women to join.

It is a randomised trial. The people taking part are put into treatment groups by a computer. Neither you nor your doctor will be able to decide which group you are in. And neither of you will know which group you are in.

  • Women in group 1 will have surgery only (standard treatment Open a glossary item)
  • Women in group 2 will have surgery then carboplatin and paclitaxel chemotherapy

10835 Trial Diagram

You start chemotherapy within 3 months after your surgery. You have the chemotherapy as an injection into a vein every 3 weeks. You have a total of 6 treatments.

The trial team will ask you to fill out a questionnaire at the start of the trial, every 3 months for 2 years and then every 6 months for another 3 years. Women who had chemotherapy will fill in an extra questionnaire after their 4th treatment and when they finish treatment. The questionnaire will ask about side effects and how you’ve been feeling. This is called a quality of life study.

If you agree to take part in this study, the researchers will ask for a sample of your cancer that was removed when you had surgery. If you don’t want to give this sample for research, you don’t have to. You can still take part in the trial.

Hospital visits

You see the doctor to have some tests before taking part in this trial. These tests include

  • A physical examination
  • Blood tests
  • CT scan

During chemotherapy you see the doctor every 3 weeks for blood tests and to see how you are.

Everyone sees the doctor every 3 months for 2 years and then every 6 months for another 3 years.

Side effects

The most common side effects of carboplatin and paclitaxel are

We have information on carboplatin and paclitaxel

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Nick Reed

Supported by

Danish Gynaecologic Cancer Group (DGCG)
European Network of Gynaecological Oncology Trials groups (ENGOT)
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:


Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Charlie took part in a trial to try new treatments

A picture of Charlie

“I think it’s really important that people keep signing up to these type of trials to push research forward.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think